# qinecsa.com

> AI-optimized mirror of qinecsa.com containing 160 pages totalling 86,522 words of clean markdown content, structured data, and semantic HTML. Original source: https://qinecsa.com. Last updated: 2026-08-26T20:09:20.983Z.

Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG).

## Homepage

- [Qinecsa - Drug Safety Solutions & Pharmacovigilance Services](/content/site-root.html): We are trusted, global partners connecting life science companies to the right safety solutions and pharmacovigilance services. (663 words)

## Articles & Blog Posts

- [Request a Demo of HaloPV](/content/forms/qinecsa1/form/requestademoofhalopv1/formperma/8nbnanfmiaevxjkmk9j20rdnh74skkzy3yyalu3a_xi/index.html): Fill out this form. (408 words)
- [QVW - Gold Standard Signal Detection](/content/vigilanceworkbench/goldstandardsignaldetection/index.html) (593 words)
- [our-products/vigilance-workbench/index.html](/content/our-products/vigilance-workbench/index.html) (138 words)
- [Case Studies - Qinecsa](/content/insights/case-studies/index.html): Explore Qinecsa case studies that show how our experts and technology deliver measurable impact across pharmacovigilance, clinical safety, analytics, and compliance. (304 words)
- [Vigilance Workbench Platform - Qinecsa](/content/pharmacovigilance-solutions/vigilance-workbench-platform/index.html): Qinecsa Vigilance Workbench (QVW), formerly known as CVW, streamlines signal detection, improves compliance, and strengthens pharmacovigilance efficiency. (1,618 words)
- [Capture Safety Data Right, At the Source](/content/reportum/unifiedsafetyintake/index.html): Capture complete safety data at the source. Cut follow‑ups, reduce workload, and scale pharmacovigilance intake without compromising compliance. (616 words)
- [HaloPV Demo Request](/content/forms/qinecsa1/form/halopvdemorequest/formperma/scixzkw3t3hhixxw99cqedzjfjwfwv7upjqiz0tqzh4/index.html): Fill out this form. (402 words)
- [Configurable forms factsheet](/content/wp-content/uploads/2025/02/qinecsa-reportum-pv-design-studio-pdf.html) (233 words)
- [insights/reportum-pharmacovigilance-platform/index.html](/content/insights/reportum-pharmacovigilance-platform/index.html) (145 words)
- [Reportum-eBook-Request](/content/reportum/ebook/safetydataintakesolved/index.html) (113 words)
- [Reportum - Pharmacovigilance Case Intake Platform - Qinecsa](/content/pharmacovigilance-solutions/reportum-platform/index.html): Reportum from Qinecsa streamlines pharmacovigilance case intake, improving compliance, efficiency and inspection readiness for global life sciences teams. (839 words)
- [insights/powering-the-pharmacovigilance-engine-why-ais-role-is-pivotal-now.html](/content/insights/powering-the-pharmacovigilance-engine-why-ais-role-is-pivotal-now.html) (168 words)
- [Qinecsa PV Insights Network](/content/pv/qinecsa-pv-insights-network/index.html): We are thrilled to announce the launch of the Qinecsa PV Insights Network, an initiative designed specifically for pharmacovigilance (PV) leaders in small pharma and biotech companies. This unique network aims to provide an ongoing and collaborative forum to share experiences and discuss the challenges of delivering drug safety strategies. (100 words)
- [Resources, Articles, Case Studies & Fact Sheets - Qinecsa](/content/insights/index.html): Browse our up to date resources in pharmacovigilance and drug safety, including blogs, new articles case studies and fact sheets. (382 words)
- [PV-Workflow-Automation](/content/halopv/pvworkflowautomation/index.html) (387 words)
- [Qinecsa Product Suite | Pharmacovigilance Solutions - Qinecsa](/content/pharmacovigilance-solutions/index.html): Discover the Qinecsa Product Suite to improve compliance, efficiency, and patient safety across pharmacovigilance operations. (716 words)
- [insights/harnessing-technology-to-optimize-pharmacovigilance.html](/content/insights/harnessing-technology-to-optimize-pharmacovigilance.html) (190 words)
- [Microsoft PowerPoint - Reportum Case Studies](/content/wp-content/uploads/2026/08/reportum-global-case-intake-automation-case-study-pdf.html) (193 words)
- [Microsoft PowerPoint - PVS case studies](/content/wp-content/uploads/2026/08/clinical-pharmacovigilance-biotech-case-study-pdf.html) (207 words)
- [Microsoft PowerPoint - Reportum Case Studies](/content/wp-content/uploads/2026/08/top-5-pharma-pv-scale-up-case-study-pdf.html) (205 words)
- [Microsoft PowerPoint - Reportum Case Studies](/content/wp-content/uploads/2026/08/reportum-top-5-pharma-case-study-pdf.html) (252 words)
- [PV-Workflow-Automation-eGuide](/content/halopv/pvworkflowautomationeguide/index.html) (75 words)
- [Microsoft PowerPoint - PVS case studies](/content/wp-content/uploads/2026/08/japanese-icsr-operations-case-study-pdf.html) (199 words)
- [Microsoft PowerPoint - QVW case studies](/content/wp-content/uploads/2026/08/qvw-unified-signal-surveillance-top-10-pharma-case-study-pdf.html) (324 words)
- [Microsoft PowerPoint - PVS case studies](/content/wp-content/uploads/2026/08/medical-information-call-center-case-study-pdf.html) (185 words)
- [Healthcare Analytics - Qinecsa](/content/pharmacovigilance-services/healthcare-analytics/index.html): Healthcare analytics services that turn complex data into actionable safety insights for compliance, efficiency, and patient protection (960 words)
- [Medical Device Vigilance Services - Qinecsa](/content/pharmacovigilance-services/medical-device-vigilance/index.html): Medical device vigilance to ensure compliance, efficiency and patient safety across global markets with Qinecsa’s expert, technology‑enabled delivery. (1,029 words)
- [Reportum & QVW Case Studies](/content/wp-content/uploads/2026/08/aurinia-reportum-digital-pharmacovigilance-case-study-pdf.html) (16 words)
- [Case Management for Global Pharmacovigilance - Qinecsa](/content/pharmacovigilance-services/case-management/index.html): Expert Case Management services that improve compliance, quality, and inspection readiness for global pharmacovigilance operations. (1,204 words)
- [HaloPV | Intelligent Pharmacovigilance Automation - Qinecsa](/content/pharmacovigilance-solutions/halopv/index.html): HaloPV streamlines pharmacovigilance processes, improving compliance, efficiency, and inspection readiness with expert-led automation. (1,557 words)
- [our-products/reportum-platform/index.html](/content/our-products/reportum-platform/index.html) (1,045 words)
- [Pharmacovigilance Benchmarking - Qinecsa](/content/pharmacovigilance-services/pharmacovigilance-consulting/pharmacovigilance-benchmarking/index.html): Qinecsa’s benchmarking service enables pharmaceutical companies and regulatory bodies to proactively identify areas for improvement. (865 words)
- [Pharmacovigilance Consulting & Strategic Advisory - Qinecsa](/content/pharmacovigilance-services/pharmacovigilance-consulting/index.html): PV consulting by Qinecsa delivers expert guidance, compliance support and strategic PV solutions to strengthen global safety and inspection readiness. (1,136 words)
- [Pharmacovigilance Training - Qinecsa](/content/pharmacovigilance-services/pharmacovigilance-consulting/pharmacovigilance-training/index.html): Pharmacovigilance training by Qinecsa builds compliant, confident and inspection ready PV teams through expert, global standard training programs. (825 words)
- [Quality & Compliance Expertise - Qinecsa](/content/pharmacovigilance-services/quality-compliance/index.html): Qinecsa provide quality and compliance services to support clients in audit and inspection readiness. (982 words)
- [Signal Detection and Management - Qinecsa](/content/pharmacovigilance-services/signal-risk-management/signal-detection-and-management/index.html): Advanced Signal Detection and Management to strengthen compliance, accelerate insights, and protect patients with Qinecsa’s global pharmacovigilance expertise. (829 words)
- [Medical Review of ICSRs | Pharmacovigilance - Qinecsa](/content/pharmacovigilance-services/case-management/medical-review-of-icsrs/index.html): Medical review of ICSRs by Qinecsa delivers expert clinical assessment, compliance and high quality case evaluation to strengthen global patient safety. (944 words)
- [Advanced Technology for Comprehensive Drug Safety - Qinecsa](/content/our-company/index.html): At Qinecsa, we are specialists in technology led end-to-end pharmacovigilance solutions (565 words)
- [Cookie Policy - Qinecsa](/content/cookie-policy/index.html): We use Essential and Non-Essential Cookies on our website. Essential Cookies guarantee functions without which you would not be able to use this website as… (716 words)
- [Next Generation Literature Management - Qinecsa](/content/our-solutions/next-generation-literature-management/index.html): Our cutting-edge literature screening system combines expert collaboration and AI-driven software. (363 words)
- [our-products/index.html](/content/our-products/index.html) (716 words)
- [PV Glossary - Qinecsa](/content/insights/pv-glossary/index.html): A An event for a product that a sponsor wants to monitor. It can be serious or non-serious. In Clinical studies it should be described in protocols and… (3,883 words)
- [Articles - Qinecsa](/content/insights/articles/index.html): Read the latest Qinecsa articles and partner contributions covering pharmacovigilance, clinical safety, signal and risk management, and regulatory topics. (652 words)
- [Pharmacovigilance Management Consulting - Qinecsa](/content/pharmacovigilance-services/pharmacovigilance-consulting/pharmacovigilance-management-consulting/index.html): Best-in-class Pharmacovigilance Management Consulting to improve governance, strengthen compliance, and support inspection readiness. (1,347 words)
- [Technology-Enabled Services for Pharmacovigilance - Qinecsa](/content/pharmacovigilance-services/technology-enabled-pharmacovigilance-services/index.html): Technology-enabled Services from Qinecsa deliver advanced PV technology and automation as a managed service, reducing complexity, cost and operational risk. (1,159 words)
- [End-to-End SAE and SUSAR Management - Qinecsa](/content/pharmacovigilance-services/clinical-safety-management/sae-and-susar/index.html): Expert SAE and SUSAR Management that strengthens compliance, accelerates reporting, and protects patients with Qinecsa’s global pharmacovigilance specialists. (951 words)
- [Clinical Safety Management - Qinecsa](/content/pharmacovigilance-services/clinical-safety-management/index.html): Qinecsa’s Clinical Safety Management delivers expert PV oversight, regulatory compliance, and inspection readiness for global pharma and biotech. (827 words)
- [Pharmacovigilance Services - Qinecsa](/content/pharmacovigilance-services/index.html): Pharmacovigilance Services that improve compliance, efficiency, and patient safety. Partner with Qinecsa for scalable, inspection-ready solutions. (579 words)
- [Drug Safety Physician Services - Qinecsa](/content/pharmacovigilance-services/signal-risk-management/drug-safety-physician-services/index.html): Qinecsa provides drug safety physician services to support case reviews, aggregate reporting, safety evaluation, and risk management services. (1,119 words)
- [ICSR Management - Individual Case Safety Reports - Qinecsa](/content/pharmacovigilance-services/case-management/icsr-management/index.html): Comprehensive ICSR management services, covering intake, book-in, triage, data entry, quality review, and medical review. (1,026 words)
- [Regulatory Intelligence for Pharmacovigilance - Qinecsa](/content/pharmacovigilance-services/pharmacovigilance-consulting/regulatory-intelligence/index.html): Regulatory Intelligence that keeps your pharmacovigilance operations compliant and inspection ready with real time insights and expert guidance. (940 words)
- [Local Pharmacovigilance with Global Compliance - Qinecsa](/content/pharmacovigilance-services/local-pharmacovigilance/index.html): Local pharmacovigilance by Qinecsa ensures compliant, efficient and country specific PV operations that strengthen global safety and inspection readiness. (918 words)
- [Eudravigilance Setup and Maintenance - Qinecsa](/content/pharmacovigilance-services/quality-compliance/eudravigilance-setup-and-maintenance/index.html): Eudravigilance setup and maintenance by Qinecsa ensures compliance, efficiency and inspection readiness for global pharmacovigilance teams. (831 words)
- [Fact Sheets - Qinecsa](/content/insights/fact-sheets/index.html): Explore Qinecsa fact sheets that break down complex pharmacovigilance and drug safety topics into concise, easy-to-reference information. (159 words)
- [Pharmacovigilance Audit Services - Qinecsa](/content/pharmacovigilance-services/quality-compliance/pv-audit-as-a-service/index.html): Strengthen compliance and inspection readiness with Qinecsa’s pharmacovigilance audit services for global PV excellence. (963 words)
- [Benefit Risk Management Solutions - Qinecsa](/content/pharmacovigilance-services/signal-risk-management/benefit-risk-management/index.html): Benefit Risk Management that strengthens compliance, safety and confident regulatory decisions with expert support from Qinecsa. (722 words)
- [Qualified Person for Pharmacovigilance (QPPV) Services - Qinecsa](/content/pharmacovigilance-services/quality-compliance/qppv-services/index.html): Qinecsa QPPV services provide expert pharmacovigilance leadership to safeguard patient safety in the pharmaceutical industry. (1,214 words)
- [Drug Safety and Reporting Training - Qinecsa](/content/pharmacovigilance-services/clinical-safety-management/drug-safety-training/index.html): Strengthen compliance and patient safety with Qinecsa’s Drug Safety and Reporting Training — expert, practical, regulatory aligned pharmacovigilance education. (1,112 words)
- [Latest News & Events - Qinecsa](/content/news-events/index.html): Browse our most recent articles, case studies, and fact sheets in pharmacovigilance and medical information services. (343 words)
- [Privacy Policy - Qinecsa](/content/privacy-policy/index.html): At Qinecsa we take privacy seriously. Here is how we keep data privacy at the forefront. (1,478 words)
- [Medical Information Call Center Services - Qinecsa](/content/pharmacovigilance-services/medical-information-call-center/index.html): Qinecsa’s Medical Information Call Center delivers compliant, accurate, and timely inquiry handling to strengthen patient safety and regulatory readiness (1,039 words)
- [Aggregate Reporting Management Services - Qinecsa](/content/pharmacovigilance-services/medical-writing/aggregate-reports/index.html): Qinecsa’s Aggregate Reports deliver compliant, inspection-ready safety reporting to support global pharmacovigilance and patient safety. (887 words)
- [Safety Management Plan (SMP) - Qinecsa](/content/pharmacovigilance-services/clinical-safety-management/planning/index.html): Comprehensive Safety Management Plan services that strengthen compliance, streamline clinical safety, and support global regulatory success with Qinecsa. (964 words)
- [Risk Management Plan - Qinecsa](/content/pharmacovigilance-services/medical-writing/risk-management-plan/index.html): Expert Risk Management Plans that strengthen compliance, reduce safety risks, and support global regulatory success with Qinecsa’s PV specialists. (839 words)
- [Signal & Risk Management Services - Qinecsa](/content/pharmacovigilance-services/signal-risk-management/index.html): Comprehensive Signal & Risk Management that strengthens compliance, accelerates safety insights, and protects patients with Qinecsa’s global PV expertise. (786 words)
- [Quantitative Signal Detection as a Service - Qinecsa](/content/pharmacovigilance-services/healthcare-analytics/quantitative-signal-detection-as-a-service/index.html): Strengthen safety oversight with Qinecsa’s Quantitative Signal Detection as a Service (QSDaaS). (812 words)
- [Webinars - Qinecsa](/content/insights/webinars/index.html): Explore Qinecsa webinars where our specialists share practical insights and expertise across pharmacovigilance, clinical safety, analytics and compliance. (133 words)
- [Individual Case Safety Reports (ICSR) Submissions - Qinecsa](/content/pharmacovigilance-services/case-management/submissions/index.html): Submissions services that ensure compliance, accuracy, and timely delivery across global regulatory authorities with Qinecsa’s expert pharmacovigilance team. (800 words)
- [End-to-End Case Management - Qinecsa](/content/our-solutions/end-to-end-case-management/index.html): Qinecsa is a leading global provider of end-to-end pharmacovigilance solutions. Learn more. (493 words)
- [Blogs - Qinecsa](/content/insights/blog/index.html): Read the latest Qinecsa blog covering pharmacovigilance, clinical safety, signal and risk management, and regulatory topics. (128 words)
- [Leadership Team - Qinecsa](/content/our-company/our-leadership-team/index.html): Meet our skilled and experienced leadership team here at Qinecsa where our mission to drive positive change in the Pharmacovigilance industry (428 words)
- [Careers in Pharmacovigilance & Drug Safety - Qinecsa](/content/our-careers/index.html): Discover a career working with Qinecsa’s complete pharmacovigilance and medical information services (324 words)
- [Whitepapers - Qinecsa](/content/insights/whitepapers/index.html): xplore Qinecsa whitepapers for expert insight and detailed analysis on key pharmacovigilance, clinical safety, analytics and regulatory topics. (108 words)
- [our-products/vigilance-workbench-platform/index.html](/content/our-products/vigilance-workbench-platform/index.html) (129 words)
- [Aurinia Case Study Digital PV with Reportum - Qinecsa](/content/case-studies/aurinias-digital-first-pharmacovigilance-strategy-delivers-strong-roi-with-reportum.html): Discover how Aurinia used Reportum to streamline safety data collection, improve intake efficiency, and build a scalable pharmacovigilance foundation. (728 words, Aug 10, 2026)
- [Top-5 Pharma Case Study 60% Less Manual PV Work - Qinecsa](/content/case-studies/scaling-for-success-how-reportum-reduced-manual-case-processing-by-60-for-a-global-top-5-pharmaceutical-company.html): Discover how a top-5 pharmaceutical company used Reportum to reduce manual case processing by 60% and scale safety data intake during therapy launch. (708 words, Aug 9, 2026)
- [Global Case Intake Automation Case Study - Qinecsa](/content/case-studies/automating-global-case-intake-how-reportum-delivered-up-to-70-roi-for-a-top-50-healthcare-company.html): Discover how a top-50 healthcare company automated global case intake with Reportum, reducing manual effort and achieving up to 70% ROI. (802 words, Aug 8, 2026)
- [Top-5 Pharma Case Study | PV Workforce Scale-Up - Qinecsa](/content/case-studies/scaling-safety-at-speed-supporting-a-rapid-pharmacovigilance-ramp-up-for-a-top-5-pharmaceutical-company.html): Learn how Qinecsa rapidly onboarded 800+ pharmacovigilance professionals for a top-5 pharmaceutical company during COVID-19. (512 words, Aug 6, 2026)
- [QVW Case Study Signal Surveillance for Top-10 Pharma - Qinecsa](/content/case-studies/one-platform-three-business-units-how-qvw-unified-signal-surveillance-for-a-top-10-pharmaceutical-company.html): Discover how a top-10 pharmaceutical company used QVW to unify signal surveillance across Pharma, Vaccines, and Consumer Health. (456 words, Aug 5, 2026)
- [Clinical Case Study: End-to-End Support for Biotech - Qinecsa](/content/case-studies/scalable-end-to-end-clinical-pharmacovigilance-for-a-resource-constrained-biotech.html): Discover how Qinecsa delivered end-to-end clinical pharmacovigilance services for a biotech, providing global compliance and 100% SLA performance. (588 words, Aug 3, 2026)
- [Medical Information Call Center Case Study - Qinecsa](/content/case-studies/increasing-medical-information-call-center-compliance-and-efficiency-for-a-specialty-pharmaceutical-company.html): Learn how Qinecsa improved Medical Information Call Center performance through multilingual 24/7 support, and enhanced compliance. (588 words, Aug 2, 2026)
- [The Productivity Crisis That Persist - Qinecsa](/content/resources/the-productivity-crisis-that-persists-even-now-what-will-it-take-to-free-up-pv-professionals-to-assess-safety-rather-than-coordinate-data.html): Qinecsa Director, Product Management HaloPV, Gyöngyi Mezey features in Chemistry Today, sharing insights on productivity crisis in pharmacovigilance. (150 words, Jul 28, 2026)
- [Closing the Local–Central Reconciliation Gap - Qinecsa](/content/resources/the-cases-between-two-desks-closing-the-local-central-reconciliation-gap.html): Explore the local–central reconciliation gap in pharmacovigilance, the compliance risks it creates, and how integrated PV systems support timely case processing (1,591 words, Jul 21, 2026)
- [Automation Is No Longer Optional In Pharmacovigilance - Qinecsa](/content/resources/pharmacovigilance-automation-is-accelerating-is-your-pv-operating-model-ready.html): Pharmacovigilance automation is reshaping drug safety operations. Discover how HaloPV streamlines workflows, improves compliance, and supports growth. (776 words, Jul 13, 2026)
- [Master File Falls: The Problem of PSMF Latency - Qinecsa](/content/resources/when-the-master-file-falls-behind-the-problem-of-psmf-latency.html): PSMF latency creates compliance risk when pharmacovigilance systems change faster than documentation. Learn how to reduce drift and improve oversight. (1,526 words, Jun 30, 2026)
- [Quantitative signal detection as a smaller MAH - Qinecsa](/content/resources/embracing-quantitative-signal-detection-methods-as-a-smaller-mah.html): Qinecsa COO John Cogan features in Journal of Clinical Studies, sharing insights on priorities for quantitative signal detection methods as a smaller MAH. (154 words, Jun 25, 2026)
- [Japanese ICSR Case Processing Case Study - Qinecsa](/content/case-studies/scaling-japanese-icsr-operations-with-65-bilingual-experts-in-6-months.html): Discover how Qinecsa scaled Japanese ICSR operations for a top 10 global pharmaceutical company, onboarding 65 bilingual experts. (546 words, Jun 10, 2026)
- [Continuous Safety Surveillance for Medical Devices - Qinecsa](/content/resources/continuous-safety-surveillance-for-medical-devices/index.html): Jon Messer, has been featured in MedTech Intelligence’s latest issue, where he discusses continuous safety surveillance for medical devices. (127 words, May 5, 2026)
- [From data collection to interrogation: why 2026 is the inflection point for combination product safety surveillance - Qinecsa](/content/resources/from-data-collection-to-interrogation-why-2026-is-the-inflection-point-for-combination-product-safety-surveillance.html): Qinecsa VP, Product Management QVW, Jon Messer, has been featured in chemistry Today’s latest issue, where he discusses why 2026 is the inflection point for… (142 words, Apr 30, 2026)
- [Why Regulators Must Improve Patient Safety Reporting - Qinecsa](/content/resources/regulators-must-intervene-to-drive-up-the-quality-and-impact-of-patient-safety-reporting.html): Qinecsa VP, Daniel O’Keeffe, has been published in Drug Discovery Today latest issue, where he insists regulators require higher-quality data capture. (177 words, Apr 29, 2026)
- [HaloPV 6.2 Released to Strengthen PV Compliance - Qinecsa](/content/news/qinecsa-releases-halopv-6-2-to-strengthen-global-pharmacovigilance-compliance-and-platform-stability.html): Qinecsa releases HaloPV 6.2 with improved regulatory compliance, FDA E2B (R3) readiness, enhanced stability, and scalable pharmacovigilance operations. (498 words, Apr 29, 2026)
- [How AI is Transforming the Biopharmaceutical Value Chain - Qinecsa](/content/resources/how-ai-is-transforming-the-biopharmaceutical-value-chain-how-ai-is-transforming-the-biopharmaceutical-value-chain-from-discovery-to-manufacturing.html): Qinecsa CPO, Beena Wood, has been featured in Pharm Tech’s “How AI is Transforming the Biopharmaceutical Value Chain from Discovery to Manufacturing”. (192 words, Apr 3, 2026)
- [Could GLP-1 obesity drugs break pharma’s safety infrastructure? - Qinecsa](/content/resources/could-glp-1-obesity-drugs-break-pharmas-safety-infrastructure.html): Qinecsa VP, Daniel O’Keeffe, has been published in Pharma Times latest issue, with an overview on GLP-1 overwhelming pharma safety operations. (172 words, Mar 3, 2026)
- [Realizing the Potential of AI within the PV - Qinecsa](/content/resources/realizing-the-potential-of-ai-within-the-pv/index.html): Qinecsa CPO, Beena Wood, has been featured in Pharm Tech’s latest issue, where she saw 2025 as an AI superposition in which pharmacovigilance needed better data (143 words, Feb 11, 2026)
- [Being is believing - Qinecsa](/content/resources/being-is-believing/index.html): Qinecsa VP, Product Management Reportum, Daniel O’Keeffe, has been featured in PharmaTimes Magazine latest issue (145 words, Feb 11, 2026)
- [Improved Drug Safety Needs Better Data Before AI - Qinecsa](/content/resources/improved-drug-safety-needs-better-data-before-ai/index.html): Qinecsa VP, Daniel O’Keeffe, has been published in Bio IT World latest issue “Improved Drug Safety Needs Better Data Before AI” (217 words, Jan 23, 2026)
- [Qinecsa Appoints Alex Livingstone-Learmonth as CCO - Qinecsa](/content/news/qinecsa-signals-next-growth-chapter-with-appointment-of-alex-livingstone-learmonth-as-chief-commercial-officer.html): Qinecsa signals next growth chapter with appointment of Alex Livingstone-Learmonth as Chief Commercial Officer (430 words, Jan 12, 2026)
- [Trends: AI, Impact of Policies, Data Harmonization - Qinecsa](/content/resources/trendspotting-artificial-intelligence-impact-of-global-policies-data-harmonization.html): Qinecsa COO, John Cogan, has been featured in Bio IT World latest issue, where he predicts the industry trends for the year ahead. (143 words, Jan 6, 2026)
- [Leaders in Pharma: 2026 predictions - Qinecsa](/content/resources/leaders-in-pharma-2026-predictions/index.html): Qinecsa COO, John Cogan, has been featured in EU Pharmaceutical Manufacturer latest issue, where he predicts the industry setting its sights for the year ahead. (130 words, Dec 16, 2025)
- [The Indisputable Case for AI in Pharmacovigilance - Qinecsa](/content/resources/the-indisputable-case-for-ai-in-pharmacovigilance/index.html): Qinecsa CEO, Adam Sherlock, has been published in IPI latest issue, The Indisputable Case for AI in Pharmacovigilance. (189 words, Dec 12, 2025)
- [Digital Transformation Themes of 2025 - Qinecsa](/content/resources/digital-transformation-themes-of-2025/index.html): Qinecsa CPO, Beena Wood, has been published in IPI latest issue, The Year in Review: What Emerged as the Key Digital Transformation Themes of 2025? (172 words, Dec 8, 2025)
- [Drug Safety Tech Trailblazer Joins Qinecsa - Qinecsa](/content/news/drug-safety-tech-trailblazer-joins-qinecsa/index.html): Qinecsa welcomes drug-safety tech leader Beena Wood as Chief Product Officer to drive innovation and enhance pharma safety with advanced solutions. (631 words, Dec 4, 2025)
- [That was the year that was - Qinecsa](/content/resources/that-was-the-year-that-was/index.html): Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharma Time’s latest issue, where she reflects on the importance of groundwork before forging… (140 words, Dec 4, 2025)
- [Qinecsa 2025 Events Round-Up - Qinecsa](/content/news/qinecsa-2025-events-round-up/index.html): As the year comes to a close, Qinecsa reflects on a successful 2025 filled with global engagement and innovation in pharmacovigilance. Our team participated in… (442 words, Dec 1, 2025)
- [Democratising access to signal detection - Qinecsa](/content/resources/democratising-access-to-signal-detection/index.html): Qinecsa VP, Product Management QVW, Jon Messer, has been featured in European Pharmaceutical Contractor’s latest issue, where he discusses that using… (139 words, Nov 19, 2025)
- [Applying AI to adverse event case processing - Qinecsa](/content/resources/applying-ai-to-adverse-event-case-processing/index.html): Qinecsa Chief Operating Officer, John Cogan, has been featured in Chimica Oggi Chemistry Today’s latest issue, where he discusses the impact of new therapy… (150 words, Oct 15, 2025)
- [How smaller pharma teams are rethinking safety surveillance - Qinecsa](/content/resources/how-smaller-pharma-teams-are-rethinking-safety-surveillance.html): Qinecsa VP Product Management QVW, Jonathan Messer, has been featured in Drug Discovery World’s latest issue, where he discusses that the rise in global… (154 words, Sep 22, 2025)
- [Statistical Significance: Could Small Pharma make more of Signal Detection - Qinecsa](/content/resources/statistical-significance-could-small-pharma-make-more-of-signal-detection.html): Qinecsa COO, John Coganr, has been featured in The Journal of mHealth’s latest issue, where he discusses that small pharma companies don’t need state-of-the-art… (134 words, Sep 19, 2025)
- [Staying Ahead of Regulatory Revisions - Qinecsa](/content/resources/staying-ahead-of-regulatory-revisions/index.html): Qinecsa COO, John Cogan, has been featured in The Pharma Navigator’s latest issue, where he discusses that increasing the use of advanced technologies will… (146 words, Sep 17, 2025)
- [A Critical Inflection Point: The Indisputable Case for Next-Gen Pharmacovigilance - Qinecsa](/content/resources/a-critical-inflection-point-the-indisputable-case-for-next-gen-pharmacovigilance.html): Qinecsa COO, John Cogan, has been featured in Pharmaceutical Outsourcing’s latest issue, where he discusses why adverse event case processing is an enormous… (155 words, Sep 12, 2025)
- [AI Encompassing: From Soaring Caseloads to Broadened Biopharma Territory - Qinecsa](/content/resources/ai-encompassing-from-soaring-caseloads-to-broadened-biopharma-territory.html): Qinecsa CEO, Adam Sherlock, has been featured in Pharma Times’ latest issue, where he discusses how embracing next-generation, AI-driven process automation… (166 words, Sep 12, 2025)
- [Human and Machine: A New Standard in Pharmacovigilance - Qinecsa](/content/resources/human-and-machine-a-new-standard-in-pharmacovigilance.html): Qinecsa CEO, Adam Sherlock, has been featured in Pharma Tech Outlook Europe’s latest issue, where he discusses how turning pharmacovigilance from a reactive… (181 words, Sep 12, 2025)
- [Powering the Pharmacovigilance Engine: Why AI’s Role is Pivotal Now - Qinecsa](/content/resources/powering-the-pharmacovigilance-engine-why-ais-role-is-pivotal-now.html): Qinecsa COO John Cogan is featured in European Pharmaceutical Manufacturer, where he discusses AI’s role in powering the pharmacovigilance engine. (168 words, Aug 5, 2025)
- [Qinecsa CEO featured in the Molecule to Market podcast - Qinecsa](/content/resources/molecule-to-market-podcast-feature/index.html): Qinecsa CEO Adam Sherlock joins the Molecule to Market podcast to share his insights from nearly four decades in the life sciences industry. (296 words, Jul 25, 2025)
- [Bridging the Gap to ROI: The Power of Technology Backed by Expertise - Qinecsa](/content/whitepapers/bridging-the-gap-to-roi/index.html): Download the whitepaper now to discover how Qinecsa can help your organization streamline pharmacovigilance operations while maximizing compliance and ROI. (168 words, Jul 21, 2025)
- [From Weight-loss Jabs to Ongoing Covid Vaccine Vigilance - Qinecsa](/content/resources/ai-approach-to-pharmacovigilance-case-processing/index.html): Qinecsa CEO Adam Sherlock is featured in The Journal of mHealth discussing the role of AI-enhanced adverse event case processing in pharmacovigilance. (197 words, Jul 14, 2025)
- [Press Release: Qinecsa Solutions announces acquisition of MyMeds&Me - Qinecsa](/content/acquisitions/mymedsandme/index.html): 04 April 2022, London – Qinecsa Solutions announced the acquisition of MyMeds&Me Limited (MMM). Qinecsa, a leading provider of pharmacovigilance services and… (512 words, Jun 24, 2025)
- [Press Release: Qinecsa Solutions announces acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions - Qinecsa](/content/acquisitions/insife/index.html): 21th March 2024 —Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, proudly announce its acquisition of Insife… (628 words, Jun 24, 2025)
- [Press Release: Qinecsa acquires Commonwealth Informatics - Qinecsa](/content/acquisitions/commonwealth-informatics/index.html): 15 December 2022, London – Qinecsa Solutions UK Ltd. (Qinecsa) has announced the acquisition of Commonwealth Informatics, Inc. (Commonwealth). Qinecsa… (528 words, Jun 24, 2025)
- [Harnessing Technology to Optimize Pharmacovigilance - Qinecsa](/content/resources/harnessing-technology-to-optimize-pharmacovigilance.html): Qinecsa’s Applied Clinical Trials feature explores how digital intake solutions can help operating across different regulatory markets. (186 words, May 23, 2025)
- [Fit-for-Purpose Signal Detection Solutions for PV - Qinecsa](/content/articles/fit-for-purpose-signal-detection-solutions-for-pv/index.html): Effective pharmacovigilance demands continuous monitoring of drug safety signals, a critical process that ensures accurate benefit-risk assessment while meeting… (781 words, May 12, 2025)
- [Building an Automation and AI Culture - Qinecsa](/content/articles/building-an-automation-and-ai-culture/index.html): Written by Martin Holm-Petersen, Chief Strategy Officer This will be the first in a series of articles about the application of artificial intelligence (AI) and… (1,824 words, Apr 24, 2025)
- [A Five-Year Roadmap for Technology-led PV Innovation - Qinecsa](/content/resources/a-five-year-roadmap-for-technology-led-pv-innovation.html): Qinecsa’s PI Journal feature lays out a five-year roadmap for PV transformation to help the industry shift from volume to value. (176 words, Apr 15, 2025)
- [Digital Transformation for Case Intake Webinar - Qinecsa](/content/webinars/digital-transformation-for-case-intake/index.html): Explore how digitalization is reshaping safety monitoring, improving decision-making, and driving efficiencies in pharmacovigilance processes. (341 words, Apr 11, 2025)
- [Navigating Drug Safety Challenges in Small Pharma and Biotech - Qinecsa](/content/resources/navigating-drug-safety-challenges-in-small-pharma-and-biotech.html): Qinecsa’s EPC Magazine feature highlights how small pharma and biotech firms struggle to standardize processes as they grow. (192 words, Mar 31, 2025)
- [New Chief Operating Officer at Qinecsa Solutions - Qinecsa](/content/news/get-to-know-our-coo/index.html): Get to know Qinecsa’s Chief Operating Officer, John Cogan, who brings extensive experience in operational excellence and R&D transformation. (1,396 words, Mar 19, 2025)
- [Create forms for your use cases with Reportum - Qinecsa](/content/fact-sheets/reportum-pv-design-studio/index.html): Qinecsa is an industry leader in pharmacovigilance solutions, offering configurable forms tailored to your use cases and workflows, allowing you to capture data from all sources. (129 words, Feb 26, 2025)
- [Revolutionizing Literature Screening: Challenges & Innovations - Qinecsa](/content/webinars/revolutionizing-literature-screening/index.html): Join us for a focused and dynamic 30-minute webinar where our expert speaker dives into the latest advancements in pharmacovigilance literature screening. (338 words, Feb 19, 2025)
- [Join Qinecsa at DIA 2025 Basel Conference - Qinecsa](/content/news/join-qinecsa-at-dia-2025/index.html): Qinecsa is thrilled to be exhibiting at the DIA EU, from March 18-20 2025 in Basel, Switzerland. (289 words, Feb 18, 2025)
- [Industry Outlook 2025 - Part 2: Shifting Political Landscapes - Qinecsa](/content/articles/industry-outlook-2025-part-2/index.html): Pharmaceutical Technology continues its insightful conversation with Qinecsa Solutions’ Adam Sherlock examining how shifting political landscapes in the US and… (168 words, Jan 29, 2025)
- [Industry Outlook 2025 - Part 1: Through the Lens of a Service Provider - Qinecsa](/content/articles/industry-outlook-2025/index.html): Industry Insights – Pharmaceutical Technology talks to Qinecsa Solutions’ CEO, Adam Sherlock about the outlook for the Life Sciences industry in 2025… (206 words, Jan 28, 2025)
- [Join Qinecsa at DIA 2025 Baltimore Conference - Qinecsa](/content/news/join-qinecsa-at-dia-2025-pharmacovigilance-risk-management-strategies-conference.html): Qinecsa is thrilled to announce exhibiting at the DIA Pharmacovigilance & Risk Management Strategies Conference, from January 27-29, in Baltimore, MD. (318 words, Jan 7, 2025)
- [PharmaVoice’s Crystal Ball: The industry’s AI future - Qinecsa](/content/articles/pharmavoices-crystal-ball/index.html): We’re proud to share that Martin Holm-Petersen, Qinecsa’s Chief Technology & Innovation Officer, is featured in Clinical Research News. (151 words, Jan 6, 2025)
- [HaloPV 6.0: One unique solution for all your PV system needs - Qinecsa](/content/webinars/halopv-6-0/index.html): The HALOPV 6.0 webinar on December 5, 2024, showcased the platform’s latest features, designed to enhance case processing and global compliance through cutting… (278 words, Dec 10, 2024)
- [New CEO for Class-Leading Pharmacovigilance Specialist - Qinecsa](/content/news/high-profile-ceo-appointment-signals-major-new-growth-phase-for-class-leading-pharmacovigilance-specialist-qinecsa.html): Veteran safety & PV leader Adam Sherlock will capitalize on Qinecsa’s deep domain expertise. (726 words, Oct 8, 2024)
- [What is Pharmacovigilance? - Qinecsa](/content/articles/what-is-pharmacovigilance/index.html): Pharmacovigilance is a critical component of the medicinal product lifecycle, focusing on ensuring the safety and efficacy of medicinal products from pre… (3,515 words, Aug 30, 2024)
- [Report: The Dynamics of Drug Safety in Small Pharma, Biotech, and Medical Devices - Qinecsa](/content/articles/pv-insights-network-benchmarking-report-the-dynamics-of-drug-safety-in-small-pharma-biotech-and-medical-devices.html): Drug safety is critical to protect patients and consumers exposed to pharmaceutical development and commercialized drugs. Although the principal framework for… (181 words, Apr 9, 2024)
- [PV Insights Network White Paper: Key challenges to address pharmacovigilance needs - Qinecsa](/content/whitepapers/pv-insights-report-key-challenges-to-address-pharmacovigilance-needs.html): Drug safety leaders speak There are thousands of small pharma and biotech companies around the world. Yet when it comes to drug safety… (115 words, Feb 19, 2024)
- [Join Qinecsa at DIA Europe 2024 - Qinecsa](/content/events/join-qinecsa-at-dia-europe-2024/index.html): Qinecsa is excited to be exhibiting for the first time at the DIA Europe regional annual meeting from 12-14 March at the SQUARE Brussels Meeting Centre in… (285 words, Feb 8, 2024)
- [End-to-End Case Management Fact Sheet - Qinecsa](/content/fact-sheets/end-to-end-pharmacovigilance-solutions/index.html): Qinecsa is a leading global provider of end-to-end pharmacovigilance solutions. Our team of pharmacovigilance specialists leverage technology solutions to… (116 words, Feb 1, 2024)
- [Vigilance Workbench Platform Fact Sheet - Qinecsa](/content/fact-sheets/vigilance-workbench-platform/index.html): The Vigilance Workbench signal detection platform spans the full spectrum of the signal management process to ensure all potential signals are tracked with… (129 words, Feb 1, 2024)
- [Global Medical Information Call Center - Qinecsa](/content/fact-sheets/global-medical-information-call-center/index.html): Qinecsa provides industry-leading medical and safety call center services led by our team of highly experienced specialists. Our teams provide support covering… (151 words, Feb 1, 2024)
- [Join Qinecsa at DIA Global Pharmacovigilance and Risk Management Strategies Conference - Qinecsa](/content/events/dia-global-pharmacovigilance-risk-management-strategies-2024.html): Qinecsa’s team of experts is looking forward to connecting with you at the DIA Global Pharmacovigilance and Risk Management Strategies Conference 2024. (228 words, Jan 5, 2024)
- [Qinecsa appoints John Freeman JD, M.Sc., B.Sc. to the Board of Directors - Qinecsa](/content/news/qinecsa-appoints-john-freeman-to-the-board-of-directors.html): Announcement – 14th December 2023, London – Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions… (417 words, Dec 14, 2023)
- [Join Qinecsa at J.P. Morgan Healthcare Conference 2024 - Qinecsa](/content/events/join-qinecsa-at-j-p-morgan-healthcare-conference-2024.html): Qinecsa is on a mission to drive positive change in the pharmacovigilance industry. As we enter a new year with exciting plans to continue advancing… (211 words, Dec 6, 2023)
- [Qinecsa appoints Arthur Shih as General Counsel - Qinecsa](/content/news/qinecsa-appoints-arthur-shih-as-general-counsel/index.html): 6 November 2023, London – Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, today announced the appointment of Arthur… (297 words, Nov 7, 2023)
- [Introducing the Qinecsa PV Insights Network - Qinecsa](/content/news/introducing-the-qinecsa-pv-insights-network-connecting-peers-for-practical-drug-safety-solutions.html): We are thrilled to announce the launch of the Qinecsa PV Insights Network, an initiative designed specifically for pharmacovigilance (PV) leaders in small… (609 words, Aug 10, 2023)
- [Join Qinecsa at World Drug Safety Congress Europe, 4-5 October, Amsterdam - Qinecsa](/content/events/join-qinecsa-at-world-drug-safety-congress-europe-4-5-october-amsterdam.html): Our team is delighted to once again be attending the World Drug Safety Congress Europe, which brings together 1500+ key thought leaders to explore key… (272 words, Jul 10, 2023)
- [Fit-for-Future Sourcing for Pharmacovigilance: Embracing Change for Success - Qinecsa](/content/articles/fit-for-future-sourcing-for-pharmacovigilance/index.html): Author: Humaira Qureshi, President of Qinecsa Solutions The pharmacovigilance industry is in an unprecedented era of change. PV teams are experiencing year-on… (884 words, Jun 15, 2023)
- [Join Qinecsa at 32nd Pharmacovigilance 2023, 26-27 April, Boston - Qinecsa](/content/events/32nd-pharmacovigilance-2023-boston/index.html): Join Qinecsa at 32nd Pharmacovigilance 2023 to discuss the latest developments in pharmacovigilance, drug safety & risk management. Our President… (179 words, Apr 19, 2023)
- [Transforming Data into Decisions - Qinecsa](/content/articles/transforming-data-into-decisions/index.html): Dr Andrew Rut recently presented at the PV Legal Forum in Chicago on the importance of collecting and analyzing holistic safety data in order to make good… (265 words, Mar 18, 2023)
- [Join Qinecsa at 31st Pharmacovigilance 2023, 1-2 February, London - Qinecsa](/content/events/join-qinecsa-at-31st-pharmacovigilance-2023-1-2-february-2023-london.html): Join Qinecsa at 31st Pharmacovigilance 2023 to discuss the latest developments in pharmacovigilance, drug safety & risk management. Humaira Qureshi, President… (158 words, Jan 25, 2023)
- [Stanley Capital-backed portfolio company Qinecsa acquires Commonwealth Informatics - Qinecsa](/content/news/stanley-capital-backed-portfolio-company-qinecsa-acquires-commonwealth-informatics.html): Stanley Capital Partners LLP (SCP) has announced the acquisition of Commonwealth Informatics, Inc. (Commonwealth) by its portfolio company Qinecsa Solutions UK… (679 words, Dec 15, 2022)
- [Qinecsa Pharmacovigilance Consulting Guide - Qinecsa](/content/articles/qinecsa-pharmacovigilance-consulting-guide/index.html): Pharmacovigilance consulting is essential throughout the entire lifecycle of both commercial and clinical products. At Qinecsa, a company with a strong focus… (680 words, Dec 13, 2022)
- [Join Qinecsa at 6th ISoP Seminar, Boston - Qinecsa](/content/events/join-qinecsa-at-6th-isop-seminar-boston/index.html): Dr Andrew Rut, Senior Executive at Qinecsa will be attending the 6th ISoP Seminar on 5-6 December in Boston, US. The seminar theme is ‘Intelligent Automation in… (183 words, Nov 22, 2022)
- [Join Qinecsa at WDSC Americas, 4-5 October 2022, Boston - Qinecsa](/content/events/join-qinecsa-at-wdsc-americas-4-5-october-2022-boston.html): The World Drug Safety Congress Americas brings together over 1000 top leaders and stakeholders in biopharma to discuss the key challenges they are facing in… (261 words, Sep 14, 2022)
- [Join Qinecsa at WDSC EU, 27-29 September 2022, Amsterdam - Qinecsa](/content/events/join-qinecsa-at-wdsc-eu-27-29-september-2022-amsterdam.html): The World Drug Safety Congress Europe brings together over 700 key thought leaders to explore the top challenges within pharmacovigilance. This year’s agenda… (262 words, Sep 12, 2022)
- [Drug Safety and Pharmacovigilance Services Solutions (DSS) rebrand as Qinecsa Solutions - Qinecsa](/content/news/drug-safety-and-pharmacovigilance-services-solutions-dss-rebrand-as-qinecsa-solutions.html): Patient safety is at the forefront of pharmacovigilance. In a demanding and constantly evolving field, life science companies need expert partners with the… (319 words, Jul 12, 2022)

## About Pages

- [Contact Our Sales & Service Team - Qinecsa](/content/contact/index.html): Contact our team to learn more about Qinecsa and our complete pharmacovigilance and medical information services (190 words)

## Resources

- [Full Page Index](/index.html): Browse all cached pages with rich metadata
- [About This Cache](/about.html): Methodology, technical details, and usage guidelines
- [XML Sitemap](/sitemap.xml): Machine-readable sitemap for crawler discovery
- [Robots.txt](/robots.txt): Crawler directives
- [AgentSite Network](https://agentsite.network/network.html): Public index of AgentSites and their machine-readable resources